Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
Workday
WDAY
US Stock MarketDetailed Quotes
ACAD ACADIA Pharmaceuticals
- 14.730
- -0.100-0.67%
Close Apr 25 16:00 ET
- 14.890
- +0.160+1.09%
Pre 04:03 ET
2.46BMarket Cap10.83P/E (TTM)
14.830High14.470Low957.58KVolume14.785Open14.830Pre Close14.07MTurnover0.84%Turnover Ratio10.83P/E (Static)166.79MShares20.68052wk High3.35P/B1.68BFloat Cap13.40052wk Low--Dividend TTM114.38MShs Float58.720Historical High--Div YieldTTM2.43%Amplitude0.650Historical Low14.692Avg Price1Lot Size
ACADIA Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 72.26%755.99M | 72.26%755.99M | 63.43%565.33M | 33.45%500.94M | 16.79%470.52M | 5.29%438.87M | 5.29%438.87M | -20.77%345.92M | -13.97%375.38M | -9.67%402.87M |
| -Cash and cash equivalents | 69.40%319.59M | 69.40%319.59M | 58.00%155.15M | 64.10%177.13M | -29.62%204.75M | 64.27%188.66M | 64.27%188.66M | -36.59%98.19M | -22.81%107.94M | 41.96%290.9M |
| -Short-term investments | 74.42%436.4M | 74.42%436.4M | 65.58%410.18M | 21.08%323.81M | 137.35%265.78M | -17.14%250.21M | -17.14%250.21M | -12.07%247.73M | -9.81%267.44M | -53.55%111.98M |
| Receivables | 2.29%104.7M | 2.29%104.7M | 16.75%110.36M | 31.18%110.39M | 42.46%100.08M | 62.25%102.35M | 62.25%102.35M | 68.40%94.53M | 22.16%84.16M | 10.66%70.25M |
| -Accounts receivable | 0.48%98.74M | 0.48%98.74M | 5.83%98.21M | 26.69%103.7M | 43.67%94.7M | 58.00%98.27M | 58.00%98.27M | 66.51%92.8M | 20.45%81.85M | 5.11%65.92M |
| -Accrued interest receivable | 45.87%5.96M | 45.87%5.96M | 602.54%12.15M | 190.58%6.7M | 24.06%5.38M | 361.36%4.08M | 361.36%4.08M | 329.28%1.73M | 146.15%2.3M | 463.72%4.34M |
| Inventory | -38.72%21.95M | -38.72%21.95M | 193.92%61.04M | 677.53%71.53M | 916.18%61.94M | 439.77%35.82M | 439.77%35.82M | 255.37%20.77M | 45.39%9.2M | -13.04%6.1M |
| Prepaid assets | 42.44%55.68M | 42.44%55.68M | 35.84%51.55M | 92.74%46.06M | 80.95%42.76M | 82.69%39.09M | 82.69%39.09M | 65.05%37.95M | 14.05%23.9M | -8.24%23.63M |
| Total current assets | 52.29%938.32M | 52.29%938.32M | 57.92%788.28M | 47.96%728.92M | 34.29%675.3M | 21.30%616.13M | 21.30%616.13M | -4.29%499.17M | -7.49%492.63M | -7.26%502.85M |
| Non current assets | ||||||||||
| Net PPE | -10.06%50.79M | -10.06%50.79M | -13.30%48.24M | -1.81%56.53M | -1.83%58.65M | -8.32%56.47M | -8.32%56.47M | -11.87%55.64M | -10.64%57.58M | -9.09%59.75M |
| -Gross PPE | -7.60%61M | -7.60%61M | -13.30%48.24M | -1.81%56.53M | -1.83%58.65M | -5.26%66.02M | -5.26%66.02M | -11.87%55.64M | -10.64%57.58M | -9.09%59.75M |
| -Accumulated depreciation | -6.92%-10.22M | -6.92%-10.22M | ---- | ---- | ---- | -18.02%-9.56M | -18.02%-9.56M | ---- | ---- | ---- |
| Goodwill and other intangible assets | 82.90%119.78M | 82.90%119.78M | 57.83%105.52M | 58.11%107.86M | 58.38%110.2M | --65.49M | --65.49M | --66.86M | --68.22M | --69.58M |
| Other non current assets | 625.31%78.87M | 625.31%78.87M | 220.32%34.83M | -14.61%20.79M | -52.64%10.95M | -40.52%10.87M | -40.52%10.87M | -38.93%10.87M | 53.96%24.35M | 41.78%23.13M |
| Total non current assets | 87.79%249.44M | 87.79%249.44M | 41.40%188.58M | 23.34%185.18M | 17.94%179.81M | 66.30%132.83M | 66.30%132.83M | 64.78%133.37M | 87.10%150.14M | 85.86%152.46M |
| Total assets | 58.59%1.19B | 58.59%1.19B | 54.44%976.87M | 42.21%914.1M | 30.49%855.1M | 27.41%748.96M | 27.41%748.96M | 4.99%632.54M | 4.90%642.77M | 4.97%655.31M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 47.63%28.21M | 47.63%28.21M | -8.10%19.08M | 5.69%19.88M | 10.96%19.33M | 45.60%19.11M | 45.60%19.11M | 107.45%20.76M | 58.69%18.81M | 61.79%17.42M |
| -accounts payable | -7.70%16.19M | -7.70%16.19M | 55.00%19.08M | 5.69%19.88M | 10.96%19.33M | 37.64%17.54M | 37.64%17.54M | 23.00%12.31M | 58.69%18.81M | 61.79%17.42M |
| -Total tax payable | 668.29%12.02M | 668.29%12.02M | ---- | ---- | ---- | 314.85%1.56M | 314.85%1.56M | --8.45M | ---- | ---- |
| Current accrued expenses | 74.92%320.15M | 74.92%320.15M | 91.48%278.89M | 109.01%281.46M | 55.65%274.75M | 143.45%183.02M | 143.45%183.02M | 112.51%145.65M | 83.33%134.66M | 125.59%176.51M |
| Current debt and capital lease obligation | 5.88%9.96M | 5.88%9.96M | -0.91%8.95M | 15.59%10.47M | 13.95%10.45M | 1.07%9.41M | 1.07%9.41M | -2.17%9.03M | 0.38%9.06M | 2.56%9.17M |
| -Current capital lease obligation | 5.88%9.96M | 5.88%9.96M | -0.91%8.95M | 15.59%10.47M | 13.95%10.45M | 1.07%9.41M | 1.07%9.41M | -2.17%9.03M | 0.38%9.06M | 2.56%9.17M |
| Current liabilities | 55.31%394.87M | 55.31%394.87M | 64.09%343.95M | 79.76%337.85M | 47.39%330.6M | 102.38%254.25M | 102.38%254.25M | 79.81%209.6M | 59.70%187.94M | 87.54%224.3M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -12.06%42.04M | -12.06%42.04M | -15.97%40.42M | -5.21%47.19M | -4.38%49.19M | -9.29%47.8M | -9.29%47.8M | -10.54%48.1M | -8.99%49.78M | -7.28%51.44M |
| -Long term capital lease obligation | -12.06%42.04M | -12.06%42.04M | -15.97%40.42M | -5.21%47.19M | -4.38%49.19M | -9.29%47.8M | -9.29%47.8M | -10.54%48.1M | -8.99%49.78M | -7.28%51.44M |
| Other non current liabilities | 19.21%18.06M | 19.21%18.06M | 21.03%15.32M | 33.56%12.36M | 112.50%11.27M | 66.93%15.15M | 66.93%15.15M | 95.79%12.66M | 66.96%9.26M | 21.31%5.31M |
| Total non current liabilities | -4.53%60.09M | -4.53%60.09M | -8.26%55.74M | 0.87%59.55M | 6.55%60.46M | 1.91%62.95M | 1.91%62.95M | 0.88%60.76M | -2.00%59.03M | -5.19%56.75M |
| Total liabilities | 43.43%454.96M | 43.43%454.96M | 47.83%399.69M | 60.91%397.4M | 39.14%391.06M | 69.27%317.2M | 69.27%317.2M | 52.92%270.37M | 38.81%246.98M | 56.61%281.05M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K |
| -common stock | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | 9.32%-2.2B | 9.32%-2.2B | 5.19%-2.35B | 1.27%-2.38B | -0.07%-2.41B | -2.59%-2.43B | -2.59%-2.43B | -6.39%-2.48B | -4.82%-2.41B | -6.44%-2.41B |
| Paid-in capital | 2.60%2.94B | 2.60%2.94B | 3.01%2.92B | 3.21%2.9B | 3.28%2.88B | 3.31%2.86B | 3.31%2.86B | 3.06%2.84B | 2.61%2.81B | 2.77%2.79B |
| Gains losses not affecting retained earnings | 1,116.67%292K | 1,116.67%292K | 368.97%858K | 36.64%-339K | -4.09%-229K | 102.46%24K | 102.46%24K | 76.63%-319K | 36.54%-535K | 64.05%-220K |
| Total stockholders'equity | 69.72%732.79M | 69.72%732.79M | 59.37%577.18M | 30.55%516.7M | 23.99%464.04M | 7.83%431.76M | 7.83%431.76M | -14.92%362.17M | -8.98%395.79M | -15.86%374.26M |
| Total equity | 69.72%732.79M | 69.72%732.79M | 59.37%577.18M | 30.55%516.7M | 23.99%464.04M | 7.83%431.76M | 7.83%431.76M | -14.92%362.17M | -8.98%395.79M | -15.86%374.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
